Richard Harris

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.

In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.

Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.

Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington Star in DC.

Harris is co-founder of the Washington, DC, Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.

Harris' book Rigor Mortis was published in 2017. The book covers the biomedicine "reproducibility crisis" — many studies can't be reproduced in other labs, often due to lack of rigor, hence the book's title. Rigor Mortis was a finalist for the 2018 National Academy of Sciences/Keck Communication Award.

A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.

Updated 12:43 p.m. ET

Perhaps 5,000 people died in Puerto Rico in 2017 for reasons related to September's Hurricane Maria, according to a study that dismisses the official death toll of 64 as "a substantial underestimate."

A research team led by scientists at the Harvard T.H. Chan School of Public Health didn't simply attempt to count dead bodies in the wake of the powerful storm. Instead, they surveyed randomly chosen households and asked the occupants about their experiences.

Children and adolescents are getting fewer prescription drugs than they did in years past, according to a study that looks at a cross-section of the American population.

You might not suspect that the success of the emerging field of precision medicine depends heavily on the couriers who push carts down hospital halls.

But samples taken during surgery may end up in poor shape by the time they get to the pathology lab — and that has serious implications for patients as well as for scientists who want to use that material to develop personalized tests and treatments that are safer and more effective.

It's always appealing to think that there could be an easy technical fix for a complicated and serious problem.

For example, wouldn't it be great to have a vaccine to prevent addiction?

"One of the things they're actually working on is a vaccine for addiction, which is an incredibly exciting prospect," said Dr. Tom Price, secretary of Health and Human Services.

Doctors can save thousands of lives a year if they act promptly to identify sepsis, an often lethal reaction to infection. Sometimes called blood poisoning, sepsis is the leading cause of death in hospitals.

A 4-year-old regulation in New York state compels doctors and hospitals to follow a certain protocol, involving a big dose of antibiotics and intravenous fluids. It's far from perfect — about a quarter of patients still die from sepsis. But early intervention is helping.

If you're tracking emerging infectious agents in the United States, it's time to add a new one to the list.

The Centers for Disease Control and Prevention has identified 13 cases of a fungal infection first seen in Japan in 2009. The culprit is called Candida auris.

The fungus has appeared among hospitalized patients with cancer-damaged immune systems or other serious conditions.

American lives have been getting steadily longer, and since the 1960s that trend has been driven mostly by a remarkable reduction in heart disease. But those improvements have slowed dramatically. Scientists are now wondering whether we're approaching the end of the trend of longer, healthier lives.

That's because the steady decline in heart disease is fading.

Almost half of all Americans take prescription painkillers, tranquilizers, stimulants or sedatives, according to results of a federal survey released Thursday. The prevalent use of these drugs could help explain why millions of Americans end up misusing or abusing them.

A new study finds that employer-based programs to help people stop smoking would work better if they tapped into highly motivating feelings — such as the fear of losing money.

This conclusion flows from a study involving the employees of CVS/Caremark. Some workers got postcards asking them if they wanted a cash reward to quit smoking. One card ended up in the hands of Camelia Escarcega in Rialto, Calif., whose sister works for CVS.

In order to improve the quality of health care and reduce its costs, researchers need to know what works and what doesn't. One powerful way to do that is through a system of "registries," in which doctors and hospitals compile and share their results. But even in this era of big data, remarkably few medical registries exist.

It's becoming routine for cancer doctors to order a detailed genetic test of a patient's tumor to help guide treatment, but often those results are ambiguous. Researchers writing in Science Translational Medicine Wednesday say there's a way to make these expensive tests more useful.

Here's the issue: These genomic tests scan hundreds or even thousands of genes looking for mutations that cause or promote cancer growth. In the process, they uncover many mutations that scientists simply don't know how to interpret — some may be harmless.

Scientists have found some unexpected clues that could help explain why 51 percent of the babies born in the United States are male.

It's been a mystery why that ratio isn't 50:50, since that's what basic biology would predict. But scientists have noticed a tilted sex ratio at birth since the 17th century.

The widely held assumption is that this imbalance starts at the very moment of conception — that more males are conceived than females.

When someone asks whether we're winning the war on cancer, the discussion often veers into the world of numbers. And, depending on which numbers you're looking at, the answer can either be yes or no.

Let's start with the no.

The number of cancer deaths in this country is on the rise. It climbed 4 percent between 2000 and 2011, the latest year in official statistics. More than 577,000 people died of cancer in 2011. That's almost a quarter of all deaths. Those aren't just personal tragedies – the figure represents a growing burden on America.

When President Richard Nixon declared a war on cancer in 1971, there were high hopes that scientists were close enough to understanding the underlying causes that many cures were within reach.

We obviously haven't won the war.

In fact, a prominent cancer biologist argues that the conceptual framework for understanding cancer has come full circle over the past 40 years.

"We were really surprised to find that very few people are following the law." - Dr. Monique Anderson, cardiologist, Duke University

Many scientists are failing to live up to a 2007 law that requires them to report the results of their clinical trials to a public website, according to a study in Thursday's New England Journal of Medicine.

The U.S. surgeon general lists 21 deadly diseases that are caused by smoking. Now, a study in this week's New England Journal of Medicine points to more than a dozen other diseases that apparently add to the tobacco death toll.

To arrive at this conclusion, scientists from the American Cancer Society, the National Cancer Institute and several universities tracked nearly a million people for a decade and recorded their causes of death.

On Monday, the first 12 volunteers received an experimental Ebola vaccine in Liberia, launching vaccine trials there. Over the next year or so, scientists hope to inject 27,000 volunteers. The goal is to test two different shots that could protect people from the deadly disease.

Viruses are usually thought of as the bad guys — causing everything from Ebola and AIDS to hepatitis and measles. But scientists have been following the curious story of a particular virus that might actually be good for you.

The virus is called GB Virus-C, and more than a billion people alive today have apparently been infected with it at some point during their lives, says Dr. Jack Stapleton, an infectious disease specialist at the University of Iowa.

Researchers at Harvard and Yale have used some extreme gene-manipulation tools to engineer safety features into designer organisms.

This work goes far beyond traditional genetic engineering, which involves moving a gene from one organism to another. In this case, they're actually rewriting the language of genetics.

The goal is to make modified organisms safer to use, and also to protect them against viruses that can wreak havoc on pharmaceutical production.

Asthma affects children regardless of where they live and whether they are rich or poor. But scientists have long thought that living in poor urban neighborhoods adds an extra risk for this troublesome lung inflammation. A new study suggests that's not necessarily the case.

Asthma is often triggered by something in the environment, so in the 1960s, scientists started looking for places where asthma was especially bad.

Though the United States is still leading the world in research related to diseases, it is rapidly losing its edge, according to an analysis in the American Medical Association's flagship journal JAMA.

If you look at biomedical research around the globe, the United States funded 57 percent of that work a decade ago. The U.S. share has since dropped to 44 percent, according to the study published online Tuesday.

Ebola vaccine developers are on track to start testing their products in West Africa in about a month, the World Health Organization said at a press conference today.

And it's a race against the clock — testing will become more challenging if the number of new Ebola cases continues to drop.

Scientists say they have discovered a natural compound from bacteria that may prove to be a potent new antibiotic. This news comes at a time when many current antibiotics are losing their oomph — germs become resistant to them.

The new compound is especially intriguing because it appears that it might not lose its germ-killing potential, according to a report published Wednesday in the journal Nature.

A drug that is used worldwide to treat malaria is now being tested as a treatment for cervical cancer. This surprising idea is the result of a new laboratory technique that could have far-reaching uses.

Our story starts with Dr. Richard Schlegel at Georgetown University Medical Center. He's best known for inventing the Gardasil vaccine to protect women from cervical cancer.

There's a major flaw in many medical research studies that seems so basic that you'd think scientists would be smart enough to avoid it.

It turns out that cells studied in the laboratory often get mixed up. A researcher who thinks she is studying breast cancer cells might in fact be using melanoma cells.

It's a surprisingly common problem — even in some of the top scientific labs.

Pages